The MCC Artificial Intelligence / Machine Learning Community of Practice Group will host a panel discussion on 23 March at 11AM EDT to explore the topic: Using Machine Learning and Artificial Intelligence to Support Clinical Trials.
Panel Moderator: Keith Dorricott, MCC Ambassador
- Lucas Glass – VP, Analytics Center of Excellence, IQVIA
- Ashley Howard – Associate Director, Asset Lead, Pfizer
- Ilan Man – Head of Data Science and Analytics, Lokavant
- Jonathan Rowe – Head of R&D Quality and Risk Management, ZS Associates
This promises to be a fascinating session with representatives from those who build ML/AI models, to an end-user and an experienced consultant in the industry. We’ve already had some interesting questions submitted – on whether AI/ML is just for big pharma, and strategies for overcoming resistance, for example.
The session is open to all MCC Members – contact MCC for registration details.
Additional information about this MCC Community of Practice Group is available on the MCC website.
Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.